Crescent Capital BDC (CCAP) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
15 May, 2026Opening remarks and agenda
The meeting was called to order by the President, with the secretary and inspector of election appointed.
The agenda included the election of two Class II Directors and ratification of the independent auditor.
The meeting was held virtually, and notice was affirmed as properly given.
Overview of voting outcomes
36,969,285 common shares were entitled to vote, with over 26.8 million shares present, constituting a quorum.
Susan Yun Lee and Michael S. Segal were elected as Directors for terms expiring at the 2029 Annual Meeting.
Ratification of Ernst & Young LLP as independent auditor for fiscal year 2026 was approved by majority vote.
Q&A with stakeholders
No questions were received from stockholders during the designated Q&A session.
Latest events from Crescent Capital BDC
- Net investment income and NAV per share declined, with fee reductions and special dividends announced.CCAP
Q1 202614 May 2026 - Net investment income per share was $0.46 for Q3 2025, with NAV per share at $19.28.CCAP
Q3 20256 May 2026 - Q4 net investment income covered the dividend, with NAV at $19.10 and a strong, diversified portfolio.CCAP
Q4 20256 Apr 2026 - Virtual meeting to elect directors and ratify auditor, with online voting available.CCAP
Proxy filing1 Apr 2026 - Virtual meeting to elect directors and ratify E&Y as auditor, with strong governance oversight.CCAP
Proxy filing1 Apr 2026 - Q2 2024 NII reached $0.59/share, NAV $20.30, with strong liquidity and stable credit.CCAP
Q2 20241 Feb 2026 - Q3 net investment income rose to $0.64 per share, with strong liquidity and low non-accruals.CCAP
Q3 202414 Jan 2026 - Q4 2024 featured lower NII, stable NAV, robust liquidity, and special dividends for 2025.CCAP
Q4 202424 Dec 2025 - Board urges ratification of Ernst & Young LLP as auditor, with 2024 fees totaling $841,150.CCAP
Proxy Filing2 Dec 2025